Atrial electrophysiological effects of ibutilide infusion in humans.

Patients with persistent atrial fibrillation (AF) who respond to ibutilide infusion usually convert to sinus rhythm within 1 hour. However, little is known about the magnitude and time course of the drug's atrial electrophysiological effects. In the current study, the frequency content of the fibrillatory baseline on the ECG was used to quantify the effects of ibutilide infusion on AF. Nineteen patients (age 56 +/- 16 years) in persistent AF were studied. Nine of these were chronically treated with antiarrhythmic drugs. All subjects received ibutilide (1 mg i.v.) over 10 minutes and a second dose 10 minutes later as needed. An ECG was recorded and digitized throughout each of the 20 sessions (one patient had two separate cardioversions). A signal processing technique was then used to quantify the average rate of the fibrillatory baseline. After attenuating the QRS and T waves, the ECG was subjected to Fourier transformation. The average rate of fibrillatory activity was defined as the frequency corresponding to the peak power of this spectrum. The fibrillation rate declined by 20 +/- 12% during the initial dose of ibutilide. This effect was rapid with t1/2 = 4.2 minutes. Ibutilide induced slowing of AF was more intense and more rapid in patients who converted to sinus rhythm than in those who did not (25 +/- 5% vs 18 +/- 14% drop in rate, t1/2 3.4 minutes vs 6.3 minutes, P = 0.002). Ibutilide induced slowing of fibrillatory activity occurs rapidly and approaches steady state before the end of a 10-minute infusion. Although interaction with other antiarrhythmic drugs may have confounded the results, the speed and intensity of slowing correlated with conversion. These observations suggest that additional studies are warranted to determine if ibutilide dosing regiments can be optimized.

Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation.

BACKGROUND: Life stresses and negative emotions, such as anxiety and depression, are associated with adverse cardiac events, including arrhythmia. Patients undergoing implantation of an automatic internal cardioverter defibrillator provide a unique opportunity to characterize these relationships since all tachyarrhythmia episodes are recorded by the device. OBJECTIVES: The purpose of this study was to examine the association of emotional status after internal cardioverter defibrillator (ICD) implantation and subsequent arrhythmia events. METHODS: An analysis of data obtained in a prospective longitudinal study of responses to the ICD measured mood disturbance (Profile of Mood States; POMS) before implant and at 1, 3, 6, and 9 months postoperatively. Subjects included 144 men and 32 women with a mean age of 60 +/- 13 years and a mean left ventricular ejection fraction (LVEF) of 33 +/- 12%. Arrhythmia events were measured by self-report of shocks and by ICD device interrogation to obtain the number and type (defibrillation, cardioversion, and antitachycardia pacing) of therapies delivered by the ICD. For each time point, POMS scores of subjects who had arrhythmia events were compared with those who did not. For subjects who had ICD shocks, pre-event and post-event POMS scores were also compared. Multiple logistic regression was used at each time point to determine if clinical, demographic and psychological data could predict arrhythmia events. RESULTS: Patients with arrhythmia events had higher POMS scores throughout the 9 months of follow-up. Higher level of mood disturbance (specifically anxiety, fatigue, and confusion) at 1 and 3 months were independent predictors of subsequent arrhythmia events at 3 and 6 months after controlling for LVEF, the presence of coronary artery disease, pre-implant arrhythmia history, and the use of amiodarone and beta-blocking agents. There were no differences in POMS scores before and after ICD shocks, reinforcing the notion that negative emotions were a cause, rather than a consequence, of arrhythmia events. CONCLUSIONS: Mood disturbances, such as anxiety, may increase the risk for arrhythmia events after ICD insertion.

Patient discomfort following pectoral defibrillator implantation using conscious sedation.

BACKGROUND: The miniaturization of implantable cardioverter defibrillators (ICDs) has made pectoral implantation possible. However, postoperative pain following the procedure has not been systematically studied. The aim of the current study was to prospectively assess patient discomfort and identify factors influencing pain perception during follow-up. METHODS: Pain related to device implantation was quantified in 21 consecutive patients (age, 61 +/- 11 years; 17 men and 21 women; 16 of 21 had coronary artery disease; left ventricular ejection fraction, 32% +/- 15%) undergoing pectoral ICD implantation with conscious sedation (fentanyl 118 +/- 72 micrograms midazolam 14 +/- 9 mg). Patients completed the Visual Analogue Scale (VAS, 0-100) and the McGill Pain Questionnaire 24 hours and 1 month postoperatively. Regression analysis was used to define clinical and procedure related variables affecting patient discomfort and frequency of postoperative analgesic use. RESULTS: The mean VAS score was 34 +/- 20 24 hours postoperatively. A single (4.8%) patient described postoperative pain as severe. Pain was reported to be moderate by 10 (47.6%) patients and mild by 10 (47.6%) patients. Intraoperative fentanyl requirement was a predictor of postoperative pain (R = 0.51, P = 0.036), and procedural duration was a strong predictor of postoperative analgesic use (R = 0.75, P < 0.001). Pain at 1 month decreased to a VAS score of 19 +/- 18 (P = 0.002 vs 24 hours) and was rated to be severe, moderate, and mild by 1, 3, and 17 patients, respectively. Late pain was related to a VAS score at 24 hours (R = 0.67, P = 0.004). CONCLUSIONS: (1) Pectoral ICD implantation using conscious sedation is well tolerated. (2) Postoperative discomfort correlates with longer procedural times and larger intraoperative narcotic requirements.

Transvenous cardioverter defibrillator lead malfunction due to terminal connector damage in pectoral implants.

Lead failure places patients with implantable cardioverter defibrillators (ICD) at risk for sudden cardiac death or results in delivery of inappropriate shocks. This study describes a mechanism of lead malfunction occurring at the junction of the terminal ring with the conductor coil of the rate sensing terminal connector in one specific model of a transvenous ICD lead. We detected the problem in a population of 179 patients with a mean age of 61 +/- 10 years and a mean lead implant duration of 16 +/- 11 months. All patients underwent pectoral ICD implantation using a submuscular approach. The implanting physician chose to place the ICD on the left side in 155 patients (87%) and on the right side in 24 patients (13%). Cephalic vein cutdown provided central venous access in 147 patients (82%), and subclavian vein puncture provided access in 32 patients (18%). Follow-up examination detected lead failure in six patients (3.5% over 31 months) due to insulation damage with or without conductor coil fracture at the junction of the terminal ring and conductor coil of the IS-1 rate sense terminal. We detected lead disruption 17 +/- 9 months (range 5-31 months) after implantation. Multiple nonsustained arrhythmia episodes exhibiting nonphysiologic intervals associated with noisy rate sensing electrograms during pocket manipulation led to discovery in three patients. The other three patients presented with inappropriate device discharges confirmed by stored high-energy lead electrograms showing normal rhythm. Pacing lead impedance abnormally dropped in two patients. Impedance remained stable in the other four patients. In conclusion, the generator pocket represents an important site of ICD transvenous lead vulnerability. Lead failure may result from conductor coil and/or insulation disruption at the interface with the rate sensing terminal connector.

Non-invasive assessment of fibrillatory activity in patients with paroxysmal and persistent atrial fibrillation using the Holter ECG.

OBJECTIVE: Automatic analysis of the frequency content of the fibrillatory baseline on the surface ECG accurately reflects the average rate of atrial fibrillation (AF). This frequency measurement correlates with the behavior of AF and predicts the response to administration of ibutilide, a new antiarrhythmic drug. Neither the temporal pattern of fibrillatory frequency in spontaneous paroxysmal or persistent AF, nor its response to chronic antiarrhythmic medication has been studied so far. METHODS AND RESULTS: Holter ECG recordings were made in 20 patients during AF. One minute ECG segments were selected for analysis. The frequency content of the fibrillatory baseline was then quantified using digital signal processing. After high-pass filtering, the QRST complexes were subtracted using a template matching algorithm. The resulting fibrillatory baseline signal was subjected to Fourier transformation, displayed as a frequency power spectrum and the peak frequency (f) was determined. In 11 patients (7 male, 4 female, age 62 +/- 10 years) 31 paroxysmal AF episodes were analyzed. Duration ranged from 1 min to 665 min (115 +/- 175 min). Initial mean peak f measured 5.1 +/- 0.7 Hz (range 3.9 to 6.9 Hz). There was a positive correlation between f and AF duration (R = 0.53, p = 0.002). AF of less than 15 min duration (n = 13) showed a lower f (4.8 +/- 0.6 Hz) when compared with longer lasting episodes (n = 18, 5.3 +/- 0.7 Hz, p = 0.03). In short AF episodes f was constant, whereas in longer-lasting episodes f increased to 5.8 +/- 0.5 Hz (p < 0.001) within 5 min. In 9 patients (9 male, age 58 +/- 8 years) with persistent AF oral antiarrhythmic drugs (amiodarone n = 5, sotalol n = 3, flecainide n = 1) were given prior to electrical cardioversion for prophylaxis of AF recurrence. Frequency measurements were obtained at baseline and 3 to 5 days after initiation of drug administration. At baseline mean f measured 6.9 +/- 0.4 Hz. Frequency was reduced by antiarrhythmic drugs to 5.8 +/- 0.4 Hz (p < 0.001). CONCLUSIONS: (1) The duration of paroxysmal AF episodes can be predicted using spectral analysis of ECG recordings of AF episodes. (2) An increase in fibrillatory frequency is associated with AF persistence. (3) This technique can be used to monitor the response to antiarrhythmic medication.

Right ventricular outflow tract tachycardia as a result of blunt chest trauma.

Two patients presented with monomorphic ventricular tachycardia after blunt chest trauma. In both cases, the arrhythmia had a left bundle branch block, inferior axis morphology comparable to that seen with idiopathic ventricular tachycardia originating from the right ventricular outflow tract (RVOT). In one patient, the arrhythmia persisted and required catheter ablation. A history of cardiac trauma should be considered in patients presenting with RVOT tachycardia.

Frequency analysis of human atrial fibrillation using the surface electrocardiogram and its response to ibutilide.

This study assesses a technique for quantifying the frequency spectrum of atrial fibrillation (AF) using the surface electrocardiogram. Electrocardiograhic recordings were obtained in 61 patients during AF. After bandpass filtering, the QRST complexes were subtracted using a template-matching algorithm. The resulting fibrillatory baseline signal was subjected to Fourier transformation and displayed as a frequency power spectrum. These frequency spectra were compared to direct measurements from the right atrium and coronary sinus in 35 patients undergoing electrophysiologic study. The clinical use of this technique was explored by correlating fibrillatory frequency with the behavior of the arrhythmia in 26 patients referred for cardioversion. The electrocardiographic frequency spectrum during AF was characterized by a single peak that varied widely between patients (range 228 to 480 beats/min). There was a strong correlation between electrocardiographic peak frequency and that measured in the right atrium and coronary sinus (r = 0.79 to 0.98, p <0.0001). Episodes of AF that terminated in < 5 minutes had a lower frequency than those that persisted > 5 minutes (324 +/- 36 vs 402 +/- 78 beats/min, p = 0.001). Chronic AF (< 3 months in duration) had a lower frequency than chronic AF (present > 3 months) (336 +/- 48 vs 408 +/- 60 beats/ min, p = 0.012). Fibrillation frequency was an accurate predictor of conversion with ibutilide. Success rate was 100% in patients with peak frequency < 360 beats/min versus 29% in patients with frequencies > or = 360 beats/min (p = 0.003). Automatic analysis of the frequency content of the fibrillatory baseline on the surface electrocardiogram accurately reflects the average rate of AF. This measurement correlates with the clinical pattern of the arrhythmia and predicts the response to administration of ibutilide.

Effect of electrophysiologic properties and location of manifest accessory pathways on local electrogram intervals at effective radiofrequency ablation sites.

The purpose of this study was to determine if the electrophysiologic properties and the anatomic location of manifest accessory pathways affect the local electrogram intervals recorded at sites of successful radiofrequency ablation. Accessory pathways in 149 consecutive patients were categorized according to their anatomic location on the basis of the site of successful ablation. Three anatomic groups comprised 90 left free wall, 28 right free wall, and 31 posteroseptal pathways. The accessory pathways were also categorized according to their electrophysiologic properties on the basis of a hierarchical classification of the accessory pathway block cycle length. Four electrophysiologic groups (A, B, C, and D) comprised 54, 51, 28, and 16 accessory pathways, with mean accessory pathway block cycle lengths of 254 +/- 9, 288 +/- 10, 347 +/- 19, and 458 +/- 56 msec, respectively. The local atrial to ventricular (A-V) and atrial to accessory (A-K) pathway electrogram intervals recorded in sinus rhythm at the successful ablation site were significantly affected by the electrophysiologic group and were longest in group D compared with groups A, B, and C (A-V interval F(3,145) = 13.6, p < 0.001; A-K interval F(3,88) = 12.6, p < 0.001). The local A-V interval was also affected by the anatomic group and was longer in posteroseptal compared with free wall accessory pathways (F(2,146) = 15.0, p < 0.001). In contrast, the timing of the local ventricular activation to the delta wave onset (delta-V) was not significantly affected by the electrophysiologic group or the anatomic location of the accessory pathway. Thus the local A-V interval at the successful ablation site may vary because it is affected by the electrophysiologic properties and location of the accessory pathway, whereas the delta-V interval remains unaffected. These effects should be taken into account when selecting ablation sites in patients with manifest accessory pathways.

Anatomy of atrioventricular nodal reentry investigated by intracardiac echocardiography.

Intracardiac echocardiography was used to evaluate posteroseptal space anatomy in patients with atrioventricular nodal reentrant tachycardia compared with patients with other mechanisms of tachycardia. The posteroseptal space was found to be significantly wider in patients with atrioventricular nodal reentry, suggesting an anatomic basis for dual atrioventricular nodal physiology.

Incidence and implications of abrasion of implantable cardioverter-defibrillator leads.

Severe abrasion of implantable cardioverter-defibrillator leads is frequently found during abdominal generator replacement and occasionally results in lead system failure. Careful inspection of leads at the time of generator replacement will identify such abrasions, and, in some cases, lead repair or replacement may be indicated.

Comparison of three different automatic defibrillator implantation approaches: pectoral implantation using conscious sedation reduces procedure times and cost.

Recent technological advances in implantable defibrillator systems (ICD) have changed implantation approaches. The aim of this study was to investigate the influence of these improvements on procedure times, implant-related charges, patient recovery, and morbidity. Ninety-six consecutive patients undergoing implantation of a nonthoracotomy ICD were studied. Implantation was performed under general anesthesia with the generator placed abdominally in 22 patients (group I) and pectorally in 40 patients (group II). Thirty-four patients underwent pectoral implantation using conscious sedation (group III). Groups were comparable with respect to clinical variables. Implantation duration and total procedure duration were shorter in group III (67 +/- 21 minutes and 117 +/- 30 minutes) when compared with group I (100 +/- 25 minutes and 157 +/- 39 minutes) and group II (86 +/- 24 minutes and 153 +/- 34 minutes, P < 0.05). Patients in group III did not require admission to the Post-Anesthesia Care Unit. In contrast, patients in groups I and II spent 92 +/- 28 minutes and 91 +/- 31 minutes in the Post-Anesthesia Care Unit. Implantation-related charges were reduced in patients having pectoral implantation using conscious sedation ($1451 +/- 217 vs. $2354 +/- 550 and $2796 +/- 384, P < 0.05). Patients in group III had a lower frequency of postoperative oral analgesic use (3.2 +/- 2.7 doses, P < 0.05) and a shortened post-operative length of stay (1.9 +/- 1.6 days, P < 0.05) when compared with groups I (5.7 +/- 4.0 doses and 3.3 +/- 1.4 days) and II (5.2 +/- 3.5 doses and 2.6 +/- 1.1 days). The overall complication rate was low (6.3%), with no differences between groups. Advances in ICD technology have simplified implantation, leading to shorter, less painful, and less expensive procedures.

[Transcatheter subendocardial infusion: a novel technique for ablation of atrial arrhythmias]. / Direkte subendokardiale Katheterinfusion als neues Ablationsverfahren von rechtsatrialen Arrhythmien.

UNLABELLED: Ablation of typical atrial flutter using radiofrequency energy is limitted by difficulties in creating a continuous line of block across the istmus between the tricuspid anulus and the inferior vena cava. Recent studies from our laboratory have shown that a novel infusion ablation technique can create large endocardial lesions in a safe and predictable fashion. The purpose of our study was to assess the feasibility of transcatheter subendocardial infusion of a mixture of 95% enthanol, iodinated contrast and glycerin to create atrial lesions resulting in complete ablation of the critical isthmus mediating typical atrial flutter. METHODS: Seven closed-chest dogs (weight 24+/-1 kg) were studied during general anesthesia with isoflurane. Two transcatheter subendocardial infusions of 0.5 cc of ethanol, contrast medium and glycerin were made over an injection time of 5 s into the posterior right atrial isthmus in each dog. Staining of the target site was monitored on fluoroscopy. Sinus rate, AH interval and AV block cycle length were determined before and after infusion ablation. Arterial blood pressure and right atrial pressure were continuously recorded. Six infusion ablations were also performed in the lateral wall of the right atrium. Lesion dimensions were measured pathologically, thereafter. RESULTS: A total of 14 infusions was made in the isthmus of the right atrium. The mean lesion volume was 0.21+/-0.18 cc. The lesions were 6+/-3 mm in width, the length was 12+/-5 mm and the average deepness was 6+/-4 mm. An ablation of the entire isthmus was, achieved in five dogs. Disturbances in AV conduction were not observed after ablation in any dog. The isthmus lesions were not proarrhythmic during programmed stimulation. 4/6 infusion ablations in the lateral atrial wall caused a penetration of contrast media of the pericardial sac. Hemodynamic deterioration was not seen after any ablation attempt. CONCLUSIONS: Direct subendocardial insusions can be used to create large ablation lesions in the posterior right atrium. The lesion size is predictable and can be directly visualized on fluoroscopy. Infusion ablations into the right atrial isthmus do not cause damage to the AV node or to the right coronary artery. Transcatheter infusions in the posterior right atrium seem to be promising for ablation of the entire isthmus mediating typical atrial flutter. Additional studies of this technique in an arrhythmia model seem warranted.

Electrical remodeling in atrial fibrillation. Time course and mechanisms.

BACKGROUND: Atrial fibrillation is self-perpetuating, suggesting that the tachyarrhythmia causes electrophysiological changes that contribute to the progressive nature of the disease. In animal models, pacing-induced rapid atrial rates result in sustained atrial fibrillation. This is mediated by shortening of refractory periods termed electrical remodeling. The purpose of the present study was to characterize the time course of electrical remodeling and to define mechanisms of the phenomenon. METHODS AND RESULTS: Closed-chest dogs were anesthetized, pretreated with atropine and propranolol, and subjected to 7 hours of atrial pacing at 800 bpm. The effective and absolute refractory periods (ARP and ERP) were measured during and after rapid pacing, and transvenous endocardial biopsy specimens were examined using electron microscopy. Despite autonomic blockade and the absence of change in right atrial pressure, persistent atrial tachycardia caused ARP and ERP to fall by > 10%. Electrical remodeling developed quickly, with more than half of the phenomenon occurring during the first 30 minutes of high-rate pacing. Pretreatment with glibenclamide in doses sufficient to block the ATP-sensitive potassium current had no effect. Atrial electrical remodeling was blocked by verapamil and accentuated by hypercalcemia. Biopsy specimens from controls subjected to rapid pacing showed mitochondrial swelling consistent with calcium overload. Biopsies from verapamil-treated animals were normal. CONCLUSIONS: Atrial electrical remodeling develops quickly, is progressive, and may be persistent. Shifts in autonomic tone, atrial stretch, or depletion of high-energy phosphates do not contribute significantly to the phenomenon. Results of the study suggest that atrial electrical remodeling is mediated by rate-induced intracellular calcium overload.

Effects of high energy shocks on pacing impedance during transvenous ICD implantation.

The purpose of the current study was to characterize the effects of transvenous ICD shocks on myocardial impedance. Rather than recording impedance during shocks, it was measured during continuous pacing in order to minimize confounding effects such as electrode polarization. Pacing impedance (reflecting the combined impedances of the electrode-tissue interface, myocardium, and blood pool) was measured every 5 seconds before and after 58 single shocks in 22 patients undergoing ICD implantation with a Transvene (n = 14) or Endotak (n = 8) lead. There was a progressive and long-lasting decrease in impedance after shocks. The magnitude of this change was similar for 0.6-J test shocks and shocks > or = 5 J (28 +/- 32 omega vs 23 +/- 16 omega; P = 0.8). However, the drop in impedance was more abrupt after high energy shocks. Because impedance continued to decline throughout the 5-minute interval between shocks, successive shocks had a cumulative effect, with a decrease of 46 +/- 42 omega after four discharges. In conclusion, a progressive decline in pacing impedance is a characteristic response to transvenous ICD discharges.

Estimation of temperature during radiofrequency catheter ablation using impedance measurements.

Temperature monitoring during radiofrequency catheter ablation is useful but requires specialized equipment that is not generally available. Previous studies have shown that impedance characteristically decreases as the result of heating at the electrode-tissue interface. The purpose of the current study was to determine if impedance changes during radiofrequency current application could be used to estimate endocardial temperature in patients undergoing catheter ablation. Data from 43 patients treated with a thermistor ablation catheter were retrospectively analyzed. The slope of the initial 2 seconds of the impedance curve and subsequent changes in impedance were incorporated into an equation for estimation of temperature in real-time. The accuracy of this equation was assessed by prospectively comparing the calculated and measured temperatures in 19 patients. Of the 88% of energy applications that were suitable for analysis, the average difference between calculated and measured temperatures was 5.2 +/- 5.6 degrees C. The average error was < 10 degrees C in 89% of applications. The results of this study suggest that impedance measurements can be used to quantify tissue temperature in real-time during radiofrequency catheter ablation. This method is sufficiently accurate to allow titration of power output to produce temperatures in the useful range (50-80 degrees C) while avoiding excessive heating (> 90 degrees C).

Wide complex tachycardia due to automaticity in an accessory pathway.

Patients with the Wolff-Parkinson-White (WPW) syndrome have preexcited tachycardia as the result of atrial arrhythmias or antidromic reentry. This article describes a patient with persistent wide complex tachycardia due to abnormal automaticity in the accessory pathway. Radiofrequency catheter ablation resulted in simultaneous elimination of accessory pathway conduction and automaticity. Accessory pathway automaticity may be an infrequent cause of preexcited tachycardia in patients with the WPW syndrome.

Effect of accessory pathway location on the efficiency of heating during radiofrequency catheter ablation.

During radiofrequency catheter ablation of accessory pathways there is a poor correlation between applied power and temperature at target sites for catheter ablation. This study was designed to examine the relation between power and temperature during radiofrequency catheter ablation in patients with accessory pathways and to identify the factors that affect the efficiency of heating, defined as the ratio of applied power and temperature. Twenty-nine patients underwent radiofrequency catheter ablation of an accessory pathway. Among 257 energy applications, 108 were applied for ablation of a right-sided accessory pathway, 105 for a left-sided accessory pathway, and 44 for a posteroseptal accessory pathway. During each application of radiofrequency energy, temperature was continually monitored by use of an ablation catheter with a thermistor embedded in the tip of the distal electrode. During some applications of energy, fluctuations in temperature were observed. The average power, impedance, temperature, and efficiency of heating for all applications of radiofrequency energy was 37 +/- 11 W, 100 +/- 9 ohms, 53 +/- 9 degrees C, and 1.7 +/- 0.8 degrees C/W (range 0.9 degrees to 6.6 degrees C/W), respectively. The efficiency of heating varied by location (p < 0.0001), with the greatest efficiency of heating for posteroseptal energy applications (2.3 +/- 1.2 degrees C/W, which were significantly greater than for left-sided (1.8 +/- 0.8 degrees C/W; p < 0.01) or right-sided (1.2 +/- 0.4 degrees C/W; p < 0.0001) applications. Phasic fluctuation in temperature was observed during 127 (49%) energy applications, and the efficiency of heating was 1.5 +/- 0.7 degrees C/W.(ABSTRACT TRUNCATED AT 250 WORDS)